Plant-based Vaccines Market Introduction
Vaccines are the most efficacious and cost-effective mode of reducing the disease burden of infectious diseases. Vaccines help in stimulating the production of antibodies in animals and humans and provide immune protection against several diseases. The three primary vaccine production methods are cell-based vaccines, vaccines produced using investigational-manufacturing systems, and egg-based vaccines. There are several limitations of conventional methods of vaccine production such as large number of eggs are required for production of egg-based vaccines and high process fermentation facilities required for production of cell-based vaccines.
The utilization of biological systems such as insect cells, bacteria culture, and plants to manufacture vaccines have gained focus of researchers. Among these, plant-based vaccine production has become popular due to several advantages. Plant-derived vaccines can be produced cheaply in large volume. Different plants have been used in the past few years to develop plant-derived vaccines including potato, rice, carrot, maize, tomato, alfalfa, carrot, lettuce, tobacco, soybean, and peanut. Choice of the plant for development of plant-derived vaccine depends on the route of administration of the vaccine, as few plants and its derived products cannot be consumed directly.
Identify the key factors that will drive your company’s growth. Request a brochure of this report here
Plant-based Vaccines Market- Competitive Landscape
In June 2016, iBio, Inc. entered into an agreement with The Texas A&M University System for a collaborative program in plant-derived pharmaceuticals. The aim of the collaboration is to rapidly develop and test commercial, cost-effective, vaccines and therapeutic solutions for diseases such as Ebola and influenza
Founded in 2008, iBio, Inc. is based in Newark, U.S. It is a biotechnology company that develops therapeutic products and focuses on commercializing its product candidates. The company has a platform for the development and production of biologics on hydroponically grown green plants. Its product class includes therapeutic protein, vaccines, and biodefense. The plasma derived protein, C1 Esterase inhibitor, is used as a drug in HAE.
Incorporated in 1999, Medicago Inc. is located in Québec, Canada. It is a clinical-stage biopharmaceutical company that develop therapeutic proteins and novel vaccines to treat various infectious diseases. The company is using virus-like particle (VLP) technologies and a novel plant-based manufacturing to develop innovative proteins and vaccines such as vaccines for influenza, novovirus, and rotavirus.
Incorporated in 2005, Creative Biolabs based in New York, U. S. The company is a leading supplier of recombinant antibodies. The company develops wide range of antibodies. Creative Biolabs provides virus-like particles based vaccines using plant cells.
Icon Genetics GmbH
Founded in 1999, Icon Genetics GmbH is located in Halle / Saale, Germany. Icon Genetics GmbH is world leader in developing and utilizing expression systems for manufacturing of recombinant proteins in green plants. The company holds about 400 granted patents in the field of plant-based expression systems which include 46 patent families, 448 granted patents.
Expanding operations in future? To get the perfect launch ask for a custom report here
Efficacy and Affordability of Plant Based Vaccine to Drive the Plant-Based Vaccines Market
Plant-derived vaccines have several advantages over conventional vaccines including readily accepted by patients, cheap and large scale production, and stable for long-term stowage of the antigens. Plant-based vaccines could be one of the best methods to lower the disease burden of infectious diseases across the world. Additionally, plant-based vaccine contamination with plant viruses is less likely to have adverse effects on humans. However, risk of escaping the lab and allergic reactions resulting in unexpected consequences are likely to restrain the plant-based vaccines market during the forecast period.
Increase in the Research and Development Activities by Key Vendors in the Market to Offer Promising Growth Opportunities to the Plant-Based Vaccines Market
Increase in the number of research and development activities for plant-based vaccines is projected to drive the global plant-based vaccines market during the forecast period. New players are entering the plant-based vaccines market and existing players are focusing on extensive clinical trial studies for the development and production of plant-based vaccines for various therapeutic and clinical applications. For instance, Creative Biolabs is developing plant-based vaccines and also offers customized services for plant-based vaccine development. Furthermore, Medicago, Inc., a clinical stage biotech company, is cultivating several tobacco plants at Durham Research Triangle Park, the U.S., which will be used in the production and testing of flu vaccine.
Plant-Based Vaccines Market Segmentation
The plant-based vaccines market can be bifurcated depending upon:
- Plant Type
- Vaccine Type
Depending on the plant type, the plant-based vaccines market can be classified into:
Based on the vaccine type, the plant-based vaccines market can be bifurcated into:
- Viral Vaccines
Depending on the application, plant-based vaccines market can be fragmented into:
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.